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The B cell antigen receptor (BCR) plays a crucial role in adaptive immunity, since antigen-
induced signaling by the BCR leads to the activation of the B cell and production of
antibodies during an immune response. However, the spatial nano-scale organization of
the BCR on the cell surface prior to antigen encounter is still controversial. Here, we fixed
murine B cells, stained the BCRs on the cell surface with immuno-gold and visualized the
distribution of the gold particles by transmission electron microscopy. Approximately 30%
of the gold particles were clustered. However the low staining efficiency of 15% precluded
a quantitative conclusion concerning the oligomerization state of the BCRs. To overcome
this limitation, we used Monte-Carlo simulations to include or to exclude possible distrib-
utions of the BCRs. Our combined experimental-modeling approach assuming the lowest
number of different BCR sizes to explain the observed gold distribution suggests that 40%
of the surface IgD-BCR was present in dimers and 60% formed large laminar clusters
of about 18 receptors. In contrast, a transmembrane mutant of the mIgD molecule only
formed IgD-BCR dimers. Our approach complements high resolution fluorescence imag-
ing and clearly demonstrates the existence of pre-formed BCR clusters on resting B cells,
questioning the classical cross-linking model of BCR activation.
Keywords: BCR, oligomerization, electron microscopy, immuno-gold-labeling, Monte Carlo simulation, maximum-
likelihood method
1. INTRODUCTION
Cells communicate with each other and with their surround-
ings through transmembrane receptors that are embedded in the
plasma membrane. Thus, it is of high interest to understand how
these receptors and other cell surface proteins, such as adhesion
molecules or channels, are organized on the membrane. Initially it
was thought that proteins and lipids freely diffuse in membranes
and that they are randomly distributed (1). With the concept of
lipid rafts it was noted that specialized microdomains on the cell
surface exist, where some proteins are concentrated and others
are excluded (2). Although the raft concept had to be modified,
since in biological membranes they are smaller and more transient
than in artificial model membranes (3), it is clear that proteins
are not randomly distributed on the cell surface. One example
of the immune system is the T cell antigen receptor that can form
pre-clustered oligomers, called nanoclusters, on T cells (4–7). Nan-
oclusters form before and independently of any ligand encounter.
Interestingly, T cells can control the degree of TCR nanocluster-
ing, in order to regulate their avidity toward multivalent ligands
and thus their sensitivity (8–10). This indicates that studying the
nano-scale distribution of a receptor contributes to the under-
standing of the function of the receptor. Less well understood is
a potential pre-clustering of the B cell antigen receptor (BCR).
The BCR is expressed on B cells and controls the development
of these cells and their activation upon contact with the BCR’s
ligand, called antigen. The BCR is composed of the membrane-
bound immunoglobulin (mIg) molecule and a heterodimer of
the Igα (mb-1) and Igβ (B29) proteins (11). The mIg molecule
binds to the antigen and exists in different isotypes, of which the
mIgD form is the most abundant one on resting mature B cells
(12, 13). The Igα/Igβ dimer contains phosphorylatable tyrosines
in the cytoplasmic tails (14) and transmits the signal of antigen-
binding to the cytoplasmic signaling machinery. The first evidence
for BCR pre-clustering, i.e., the existence of BCR oligomers, was
obtained by Blue Native gel electrophoresis (15–17). Upon extrac-
tion of the IgD- and IgM-BCRs from the cell membrane of resting
B cells using low concentrations of detergent, the BCRs were found
in oligomers. Importantly, a mutant mIgD molecule, in which the
transmembrane region was mutated (called mIgD-hSbap), only
formed dimers (16). Thus, in the BCR as well as in the TCR
(10), the transmembrane region of the ligand-binding subunits
is involved in the pre-clustering. Later, three approaches were
used to investigate whether the BCR forms oligomers in living
cells. Firstly, a FRET approach was used, and oligomers were
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not detected (18). Secondly, a bifluorescence complementation
approach was used, and BCR oligomers were detected (19). The
differences in these two procedures and possible functional impli-
cations of pre-clustered BCR oligomers were recently discussed
(20). Thirdly, the superresolution microscopy method direct sto-
chastic optical reconstruction microscopy (dSTORM) was used
to show that BCRs were organized as pre-clusters on the surface
of resting primary B cells (21). Here, we used a validated tech-
nique, that we had previously used to study TCR pre-clustering
(6, 8), in order to answer the question of whether BCR oligomers
exist and if yes what their sizes are. To this end, we used fixed
B cells and labeled the BCRs with specific antibodies that were
bound to gold particles (immuno-gold-staining), prepared cell
surface replicas and analyzed the nano-scale distribution of the
gold particles by transmission electron microscopy (TEM). This
approach allowed visualization of BCRs on cell surface areas that
do not adhere to any experimental support, giving the opportunity
to analyze untouched (and non-modified) receptors. A general
challenge of immuno-gold-labeling is its low staining efficiency,
which is compensated by mathematical modeling and statisti-
cal methods, allowing solid conclusions to be drawn from the
experimental data.
2. MATERIALS AND METHODS
2.1. EXPERIMENTAL PROCEDURES
2.1.1. Cell culture and cell fixation
The murine B cell lines J558L (not expressing any BCR) and
J558Lδm/mb-1flN (expressing an IgD-BCR) were previously
described (16). We also used a J558L line that expressed a mutant
IgD-BCR, in which the transmembrane region of the mIgD
molecule was mutated (mIgD-hSbap) (16). Cells were cultured
in RPMI 1640 complete medium supplemented with 10% fetal
calf serum, 2 mM l-glutamine, 100 U/ml penicillin/streptomycin,
10 mM HEPES, and 50 mM 2-mercaptoethanol and grown at 37°C
in a humidified atmosphere with 5% CO2. Cells were fixed with
freshly prepared, ice-cold 4% paraformaldehyde in PBS for 20 min
at 4°C at a cell density of 10× 106 cells/ml. After fixing, cells were
washed twice with cold PBS.
2.1.2. Immuno-gold-staining and analysis of gold-reagent
Unstimulated PFA-fixed cells were stained with the primary anti-
idiotypic antibody Ac146 (22) at saturating concentration of
20 mg/ml in PBS with 1% BSA for 1 h on ice. This antibody binds
to the variable regions of the BCR used in this study. Staining
with a secondary anti-mouse IgG antibody conjugated to 10 nm
gold (Aurion) was performed for 1 h on ice. Prior to cell staining,
the aggregation state of the gold-reagent was tested by adsorbing
diluted suspensions of the gold-reagent onto collodion/carbon-
coated EM grids, which were analyzed in transmission electron
microscopy (TEM, Figure 2).
2.1.3. Surface replica preparation
Labeled cells were adsorbed to l-poly-lysine-treated micas, fol-
lowed by a second fixation with 0.1% glutaraldehyde on ice
for 30 min. Micas containing stained cells were covered with an
untreated piece of mica and fast-frozen in a Reichert-Jung (now
Leica) KF-80 plunge freezing unit using the secondary cryogen
liquid ethane. Metal replicas were prepared in a freeze fracture
unit (BAF 060; BAL-TEC) where the cell-containing mica slide
was freeze-etched at −150°C for 12 min to sublime surface ice.
Frozen cells were then shadowed with 2 nm of evaporated plat-
inum at an angle of 45°C and strengthened by a uniformly thick
20 nm electron-translucent carbon layer evaporated perpendicu-
lar to the mica surface plane. The metal replica of the surface was
released from the mica by floating it on commercial bleach where
it remained over night for digestion of the organic material. The
floating replica was washed three times in distilled water to remove
attached organic material and chemicals and then picked up on
uncoated copper EM grids. For a detailed protocol see Ref. (23).
2.1.4. Analysis of metal replicas by TEM
Replicas mounted on EM grids were examined in a transmis-
sion electron microscope (1200-EX II; JOEL) operating at 100 kV.
Gold particle numbers and the gold cluster size distribution were
counted and analyzed for at least 3 cells per sample at an augmen-
tation of 25000. Gold particles were considered to be part of the
same cluster when they were adjacent or less distant than 10 nm
(the diameter of a single gold particle), taking into account that
the diameter of the BCR is around 10 nm (24). Pictures were taken
at augmentations of 5000 (cell overview), 120000, and 300000
(gold-labeling).
2.1.5. Quantification of the number of BCRs per cell
The number of BCRs per cell was determined based on a sat-
uration binding assay. About 1× 106 J558Lδm/mb-1flN cells
were stained for 30 min at 4°C with increasing concentrations
of an FITC-coupled anti-IgD antibody (BD Pharmingen, clone
11-26c.2a). Following 5 extensive washing steps, the fluores-
cence signal was measured in duplicates using a SpectraMax 190
Absorbance Microplate Reader. In order to convert the fluores-
cence signal intensity into the number of antibodies, a calibration
of the antibody was performed by fitting the model y =mx + b
to the standard concentrations x and fluorescence signals y. Here
m denotes the slope and b denotes the intercept of the calibra-
tion curve. In order to infer the number of receptors on the cells,
antibody was spotted in different concentrations. The saturation
model y = y0+ axb+x was fitted to the sample data. Here, x denotes
the antibody concentration and y denotes the fluorescence sig-
nal after washing. The parameter y0 was measured explicitly. The
remaining parameters, i.e., the maximal fluorescence signal gain a
and the saturation constant b were estimated from the data. From
the maximum signal gain a, the corresponding concentration of
bound antibody was computed from the calibration curve, i.e.,
1x = am . Finally, the number of receptors per cell was computed
by the formula n = 1x·NA ·Vk·Ncells·M , where NA= 6.022× 1023 1/mol,
V = 50µl, k = 2, N cells= 5× 105, and M = 146.389× 103 g/mol
denote Avogadros constant, the volume per well, the number anti-
body binding sites per receptor, the number of cells, and the
molecular weight of the antibody. From the parameters obtained
by the calibration and saturation curve, we get n= 122400± 7500.
The uncertainty of the number of receptors per cell is dominated
by the uncertainty of a, the maximum signal gain. The uncer-
tainty of a is propagated to the error of n by Gaussian error
propagation.
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2.2. MONTE-CARLO SIMULATION OF OBSERVED GOLD CLUSTER SIZE
DISTRIBUTION
The immuno-gold-staining and counting process was simulated
by a Monte-Carlo approach. It is assumed that the observed
gold cluster size distribution is a superposition of distributions
generated by single size oligomers. Each oligomer size produces
a characteristic distribution of observed gold cluster sizes that
depends on the staining efficiency. The characteristic distribu-
tion ranges from exclusively monomeric observation to exclusively
single size oligomeric observation for staining probabilities zero
and one, respectively. The distributions in between zero and one
depend on the oligomer geometry, which is reflected by the num-
ber of next neighbors of an average receptor. This number is at
least 2, i.e., for linear arrangement of the receptors. For other
cases, like dense circle packing resulting in a triangular geometry
it is 6 and for a quadratic grid it is 8. Simulations have been per-
formed for linear arrangements and quadratic grids which reflect
different extremes. An additional factor for the observed size distri-
bution is the gold-reagent itself, which is potentially pre-clustered.
Further, the staining efficiency, i.e., the number of receptors that
are stained; the geometry, i.e., the receptor positions within the
oligomers being stained; and potential unspecific stainings, i.e.,
presence of gold particles that are not bound to any BCR, have to be
considered. For given oligomer size, staining efficiency, geometry,
and gold distribution, the observed gold cluster size distribution
is obtained by repeated random number generation for the num-
ber of stained receptors, their positions and the number of gold
particles per staining spot. For each set of random numbers, the
resulting representation of the gold particle pattern is evaluated by
the simulation program and the number of counted monomers,
dimers, etc., is collected. This procedure was performed 105 times
for 10 staining probabilities between 2 and 40%, underlying BCR
oligomer sizes from 1 to 40 and three geometries, i.e., linear,
triangular, and quadratic. In addition, the simulation approach
has been adapted to explain the observation of the gold-reagent
control experiment.
2.3. STATISTICAL INFERENCE
The result of each gold-staining experiment is a distribution of
gold cluster sizes determined from gold particle counting in the
microscope. These experimental data are compared to the simu-
lated data and by means of statistical methods it is decided whether
simulation and experiment are in accordance. We tested four major
hypotheses: receptors are organized as:
1. BCR oligomers of a unique fixed size s,
2. BCR monomers and oligomers of a unique fixed size s,
3. BCR dimers and oligomers of a unique fixed size s,
4. BCR monomers, dimers, and oligomers of a unique fixed size s.
For each hypothesis, a likelihood function is derived based
on the assumption of Poisson statistics for the counted gold
oligomers. The corresponding log-likelihood reads
l (θ) =
∑
i
mi (θ)− Ni log (mi (θ))+
Ni∑
k=1
log k, (1)
where mi is the number of expected BCR oligomers of size
i predicted by the simulation and Ni is the number of gold
oligomers counted in the experiment. Minimization is performed
with respect to the parameter vector θ which is defined differently
for each hypothesis. This is explicitly
m(1)i (θ) = θ · ni,sim (s) , (2)
m(2)i (θ) = θ1 · ni,sim (1)+ θ2 · ni,sim (s) , (3)
m(3)i (θ) = θ1 · ni,sim (2)+ θ2 · ni,sim (s) , (4)
m(4)i (θ) = θ1 · ni,sim (1)+ θ2 · ni,sim (2)+ θ3 · ni,sim (s) , (5)
where ni,sim(s) denotes the simulated observed gold cluster size
distribution given the underlying BCR oligomer size. I.e., the para-
meter vector θ reflects the composition of BCR oligomers on the
surface. For each simulated data set, i.e., for each triplet (staining
efficiency p, underlying cluster size s, geometry g ), the maximiza-
tion of the log-likelihood results in an estimate for the parameter
vector θ , denoted by θˆ , that explains the experimental data best.
In addition, to test if the log-likelihood value l(θˆ) is in accordance
with the data, parametric bootstrapping is employed. In paramet-
ric bootstrapping, the model prediction mi(θˆ) is used to generate
de novo observation data. In our case, 103 random samples have
been drawn from a Poisson distribution with mean mi(θˆ) and have
been treated like gold particle observations. For each sample, the
log-likelihood is maximized again and the values are collected in
a histogram approximating the asymptotic log-likelihood distri-
bution. The original value l(θˆ) is compared to different statistics
of the sampled distribution, among these p-value and weighted
distance to the mean 1 = l(θˆ)−〈l(θ)〉
σl(θ)
. The hypotheses are rejected
based on these values for p< 0.01 and1> 3, respectively.
3. RESULTS
3.1. THE WORKFLOW
Here we derived the size distribution of the IgD-BCRs on the cell
surface of J558L transfectants from the measured distribution of
gold particles after staining the BCRs with immuno-gold. “Size
distribution of the BCRs” is defined as the percentage of BCRs in a
given cluster size, such as 5% of the BCRs are in BCR monomers,
45% are in BCR dimers, and 50% are in BCR trimers. Our work-
flow consists of two phases. The first is carried out in the wet lab
and comprises immuno-gold-labeling of the BCRs on untreated
and PFA-fixed cells, followed by cell surface replica preparation
and the quantification of the gold particle cluster size distribution
on the replicated cell surface area by TEM (Figure 1, steps 1 and
2). As the staining efficiency reached by immuno-gold-labeling is
low, the obtained immuno-gold data cannot directly be converted
into the distribution of the BCRs. Thus, in the second phase math-
ematical modeling is used to derive the BCR distribution from the
gold particle data. To do so, we assume a large number of different
BCR distributions, such as only one defined size (only monomers,
or only dimers, or only trimers, etc.) or a combination of sizes (for
example, dimers and trimers). The observed gold particle size dis-
tributions are then stochastically simulated using a Monte-Carlo
simulation of the staining process, and the likelihood that the
gold size distribution represents a given BCR size distribution is
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FIGURE 1 | Scheme of the workflow. The approach is divided into six steps
partitioned into experimental (steps 1 and 2), theoretical (steps 3 and 4), and
statistical parts (steps 5 and 6). In step 1, the IgD-BCRs on the surface of
resting and fixed B cells are stained with immuno-gold and the gold particles
visualized by TEM. In step 2, the gold particles are counted, generating an
observed gold cluster size distribution. In step 3, the staining process is
simulated by Monte-Carlo procedures based on hypothetical BCR nanocluster
size distributions, generating characteristic gold particle cluster distributions
for the observed gold-labeling. Gold particles are shown in black and BCRs in
blue or red (each BCR occupies one square, thus showing a blue 8 mer and a
red dimer). In step 4, superposition parameters are estimated based on the
observed gold particle distributions by maximum-likelihood estimation. In
step 5 based on the estimated parameters, de novo, in silico cluster size
distributions are repeatedly generated and the corresponding log-likelihood is
re-optimized, providing a histogram of log-likelihood values. Step 6; if in
accordance with the data, the theory makes a valid prediction for the
underlying BCR nanocluster distribution and the relative amounts of the
nanocluster sizes is calculated.
calculated. Each single BCR oligomer size produces a characteris-
tic distribution of observed gold cluster sizes that depends on (1)
the pre-clustering of the gold-reagent, i.e., presence of monomeric,
dimeric, or trimeric gold particles in the staining reagent, (2) the
immuno-gold-staining efficiency, i.e., the percentage of BCRs that
are labeled by gold particles, (3) unspecific binding of the gold-
reagent to the B cell, independent of any BCR, (4) the oligomer
geometry which is reflected by the number of next neighbors of
an average receptor within the BCR oligomer, this number is at
least 2, i.e., for linear chains of receptors, or up to 8 for a qua-
dratic grid (Figure 3A). The Monte-Carlo simulation provides
information on the staining patterns and thus, the visible gold
cluster size distribution (step 3). To match the data, several such
gold cluster distributions are superposed with different strengths.
These strengths, called the superposition parameters, are estimated
from the data and give rise to a hypothesized underlying BCR
size distribution (step 4). Based on the estimated superposition
parameters the gold particle observation data is repeatedly gener-
ated and the parameters are re-estimated. This process results in a
distribution of log-likelihood values which, in case of good agree-
ment between model and data, contains the original log-likelihood
value l(θˆ) (step 5). For the log-likelihood value, the threshold cor-
responding to a p-value of 0.01 can be computed which when
being exceeded allows to reject the model. Otherwise, for a model
log-likelihood value in the interior of the distribution, the model
makes a valid prediction for the underlying BCR oligomer size
distribution (step 6). This means that the observed gold cluster
distribution can be fully explained by the predicted BCR oligomer
distribution.
3.2. ESTIMATION OF THE DEGREE OF PRE-CLUSTERING OF THE
GOLD-REAGENT
To address a possible pre-clustering of the gold-reagent used for the
BCR immuno-gold-labeling, the gold-reagent alone was adsorbed
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onto collodion/carbon-coated EM grids, i.e., without receptor
binding, and analyzed by TEM (Figure 2A). The few observed gold
particle dimers and trimers could be due to either pre-clustering
of the gold particles in the staining reagent or random collocation
of monomeric gold particles on the grid. The observed size distri-
bution data of the gold-reagent alone (Figure 2B) was subjected
to our workflow described above and interpreted as the staining of
one huge quadratic oligomer. The size of this quadratic oligomer
is the number of image pixels divided by the number of pixels per
gold dot. The staining efficiency was first assessed by the num-
ber of gold particles divided by the oligomer size. Subsequently,
the observed oligomer size distribution has been simulated by our
Monte-Carlo approach showing that random collocation is not
sufficient to explain the number of observed gold particle dimers
but that the gold-reagent is indeed already pre-clustered. From this
analysis, we find that 92.8% of all gold particles are monomeric,
6.5% are pre-clustered dimers, and 0.7% are pre-clustered trimers.
These numbers have been taken into account for all following
simulations by introducing parameters representing the inherent
fraction of gold dimers and trimers. A complementary perspec-
tive on Figure 2A is its interpretation as staining of a surface with
exclusively receptor monomers. This perspective enables insights
into the specificity of the approach. Testing the hypothesis “100%
monomers,” differences in the staining efficiency should not lead
to differences in the log-likelihood because only the total number
of counts but not the observed size distribution changes. In con-
trast, when testing alternative hypotheses such as“100% dimers”or
“100% trimers,” the method should allow rejecting those hypothe-
ses. Indeed, this was the case (Figure 2C). The plot shows the
weighted distance to the mean and the p-value based on the log-
likelihood. These values were computed for different hypothetical
staining efficiencies, represented by different colors, and dominant
oligomer sizes, represented by the x-axis. Already for hypothetical
staining efficiencies larger than 3% all tested hypotheses other than
“100% monomers” can be rejected with p≤ 0.001. Conversely, the
monomer assumption is not rejected for any staining efficiency, in
accordance with the expectation. This proofs that our approach is
highly sensitive as a staining efficiency of 3% is already sufficient
to reject wrong hypotheses.
3.3. CALCULATION OF THE IMMUNO-GOLD-STAINING EFFICIENCY
FOR THE IgD-BCR
Next, we calculated the staining efficiency of the BCR immuno-
gold-labeling process, using the murine B cell line J558Lm/mb-
1flN (16). These cells express IgD-BCRs on their surface, as seen
by a flow cytometric analysis using the same monoclonal anti-BCR
antibody (Ac146) that was also used for the immuno-gold-labeling
(Figure 3B). The total number of IgD-BCRs per cell was exper-
imentally determined to be 122400± 7500 BCRs (described in
the Methods section). The total cell surface area of a J558L cell
is 782± 25µm2 (25) resulting in an expected mean density of
156 BCRs/µm2. We analyzed three J558Lδm/mb-1flN cells by
immuno-gold-staining and TEM. The three areas analyzed by
TEM were 101, 183, and 152µm2 and the expected BCR number
in those areas was calculated to be 15600, 28080, and 23400 BCRs,
respectively. The achieved BCR immuno-gold-labeling efficiency
was calculated based on the number of gold particles observed in
the areas (2192, 3577, and 3876 gold particles, respectively) assum-
ing one gold particle to represent one BCR. Thus, the BCR labeling
efficiencies were 14.1, 12.7, and 16.6%, respectively. Thus, the BCR
staining efficiency in our experiment was approximately 15%.
3.4. THE ANTI-BCR IMMUNO-GOLD-STAINING IS SPECIFIC FOR THE
BCR
To prove that the anti-BCR immuno-gold-labeling protocol only
stained BCRs, we compared J558L cells that lack BCR expression
FIGURE 2 |The antibody-coupled gold-reagent is mainly monomeric.
(A) The gold-reagent alone was adsorbed onto collodion/carbon-coated EM
grids and analyzed by TEM. (B) Analysis of the clustering of 2041 gold
particles alone showed 88% monomeric gold particles, 8% of gold
particles as close as dimers, 3% were counted as trimers, and 1% as
clusters of larger sizes. (C) The gold-reagent cluster size distribution was
re-evaluated by our workflow, interpreting the cluster counts as receptor
staining. Pre-clustering of the gold-reagent was taken into account. For
different assumed receptor oligomer sizes (x -axis) and staining efficiencies
(color scale), significance level and p-value were computed (y -axis).
Models are rejected above the dashed line corresponding to a p-value of
0.01. The analysis confirms the monomer hypothesis and rejects other
hypotheses with p<0.01 (above the dashed line) for staining efficiencies
larger 3%.
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FIGURE 3 |The anti-BCR immuno-gold-labeling is specific. (A) The
Monte-Carlo simulations were performed for two possible BCR oligomer
geometries: a linear and a laminar geometry. (B) J558Lδm/mb-1flN cells
expressing the wt IgD-BCR (black line), J558L cells without any BCR (dark
gray line) or IgD-hSbap BCR-expressing J558L (light gray line) were labeled
with the anti-BCR antibody Ac146 and subsequently stained with
FITC-labeled anti-mouse IgG or gold-coupled anti-mouse IgG antibodies.
Fluorescently labeled cells were analyzed by flow cytometry, and mean
fluorescent intensities (MFI) of the gated populations are given. Gold
labeled cells were subjected to replica preparation and analyzed by TEM.
The mean gold particle (MGP) number detected on the cell replicas
confirms specific labeling of the BCR on wt and IgD-hSbap expressing
J558L cells, while immuno-gold-labeling of J558L not expressing BCR does
not result in significant gold particle detection on surface replicas.
and the J558Lδm/mb-1flN cells (Figure 3A). Flow cytometry
analysis confirmed no BCR expression on J558L cells. Immuno-
gold-labeling of the J558L cells resulted in 2 gold particles per
observed area, while J558Lδm/mb-1flN cells were stained with
3215 gold particles on average (Figure 3A). Thus (nearly) each
gold particle is representing a BCR.
3.5. DETERMINATION OF THE SIZE DISTRIBUTION OF WT IgD-BCR
OLIGOMERS
For our simulations to determine the size distribution of the wt
IgD-BCR,we have used the immuno-gold data from J558Lδm/mb-
1flN cells (Figure 4A) and the corresponding size distribution of
the gold particles (Figure 4B). The quantification of gold clusters
by TEM revealed 66% gold monomers, 21% gold in dimers, 7.5%
gold in trimers, and a fraction of 5.5% gold particles were part of
oligomers of four or more gold particles. To account for different
possible geometries of each individual BCR cluster, simulations
have been performed for linear and laminar BCR arrangements
(Figure 3B). Firstly, we have assumed a linear arrangement of
the BCRs (Figure 4C). Assuming the presence of one defined
BCR oligomer size, labeled by x, we have performed simulations
for BCR monomers (1), BCR dimers (2), BCR trimers (3), etc.
(Figure 4C, top, left panel). The different staining probabilities
are denoted by the color coding being centered around the exper-
imentally measured value of 15%. All curves outside a range of
±5% were shaded. For the single size assumption none of the
assumed BCR cluster sizes is in agreement with the data (below
the dotted line). The discrepancy between data and model does
not change any more as soon as the assumed BCR oligomer size is
larger than 6 because the observed size distribution produced by
them is almost identical. In particular, this means that linear BCR
oligomers larger than 6 or even a mixture of large BCR oligomers
is not in accordance with the experimental data at the given stain-
ing efficiency. Also a mixture of small and large BCR oligomer
sizes, e.g., 1+ x (BCR monomers and one BCR cluster size of x,
upper, right panel), 2+ x (BCR dimers and one BCR cluster size
of x, lower, left panel), or 1+ 2+ x (BCR monomers, dimers, and
one BCR cluster size of x, lower, right panel), is unable to explain
the observed data by linearly arranged receptor oligomers, thus,
leading to a full rejection of this geometry hypothesis. Secondly,
we have assumed a laminar arrangement of the BCRs (Figure 4D).
Following the plot for the single size assumption (Figure 4D, panel
x), the best agreement is obtained for small BCR oligomers such as
BCR dimers and trimers. This suggests that small BCR oligomers
contribute significantly to the overall observed gold cluster distri-
bution. Evaluation of related model hypotheses, 1+ x, 2+ x, and
1+ 2+ x shows that monomers plus an additional BCR oligomer
size is not sufficient to explain the observed size distribution. How-
ever, accordance can be achieved for BCR dimers plus a large BCR
oligomer around a size of 18 (lower, left panel). Additional BCR
monomers do not further reduce the discrepancy between model
and data (lower, right panel). This is also expressed in Figure 4F.
BCR dimers dominate the small observed gold particle oligomers
up to a size of 3, where BCR dimers are occasionally observed as
trimers due to the pre-clustering of the gold-reagent. Underlying
BCR oligomers of size 18 take over beginning from an observed
gold particle size of 4. The contribution by BCR monomers is
negligible. When testing a model with several BCR oligomer sizes,
e.g., 1+ 2+ 18, the maximization of the log-likelihood gives an
estimate for the ratio between the abundance of the single BCR
oligomer sizes. This ratio is then expressed in the percentage of
receptors being contained in either of the oligomers. The number
of receptors in oligomers of each size, computed from the model,
indicates that 60% of all receptors are contained in BCR oligomers
of size 18, 40% are contained in BCR dimers and BCR monomers
are negligible (Figures 4E,F). In conclusion, we suggest that IgD-
BCRs are arranged in pre-formed BCR oligomers on the surface
of J558Lδm/mb-1flN B cells and that BCR dimers as well as large
BCR oligomers of a laminar geometry co-exist.
3.6. DETERMINATION OF THE SIZE DISTRIBUTION OF A MUTANT
IgD-BCR THAT MOSTLY FORMS DIMERS
To validate our combined experimental and theoretical approach,
we took advantage of a transmembrane mutant IgD-BCR (IgD-
hSbap BCR), which resulted in impeded BCR oligomerization as
detected by Blue Native gel electrophoresis and pre-dominant
detection of BCR dimers (16). Immuno-gold-labeling of the
mutant BCR and sampling were performed as above. The quan-
tification of gold clusters by TEM revealed mainly gold monomers
(83%) and dimers (13%), and a smaller fraction of gold oligomers
of three or more gold particles (4%) (Figures 5A,B). In contrast
to the wt IgD-BCR, the staining efficiency was not determined
as mutant IgD-BCR expression was heterogeneous (Figure 3B).
When evaluating the log-likelihood for BCR staining efficiencies
up to 40% and dominant BCR oligomer sizes up to10, the over-
all best log-likelihood value was achieved for BCR dimers at a
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FIGURE 4 |The IgD-BCR forms differently sized oligomers on the
surface of B cells. (A) IgD-BCR-expressing J558Lm/mb-1flN cells were
immuno-gold stained using the mouse anti-BCR antibody Ac146 and
anti-mouse IgG antibodies coupled to gold particles of 10 nm. The cell
overview is given at low magnification (upper left panel), gold-labeling of the
cell surface is shown in an overview picture (right panel) and individual gold
clusters are shown at high magnification (lower left panel). (B) 66% of the
gold particles were present as monomers, 21% formed dimers, 7.5%
trimers, and 5.5% were present in clusters of sizes larger than 3. (C) The
observed gold particle cluster size distribution was simulated with the
assumption of an underlying linear BCR oligomer geometry. Simulations
were performed for staining efficiencies of 15±5% indicated by colored
lines. The BCR oligomer sizes tested are indicated on the x -axis, and the
sigma/p-values for the statistical analysis of each simulation set is given on
the y -axis. Different hypothetical BCR oligomer size distributions are tested,
namely “one BCR oligomer size only” (x, upper left panel), “BCR
monomers+ another single BCR oligomer size” (1+ x, upper right panel),
“BCR dimers+ another single BCR oligomer size” (2+ x, lower left panel),
and “BCR monomers, dimers+ another single BCR oligomer size”
(1+2+ x, lower right panel). Models are rejected above the dashed line
corresponding to a p-value of 0.01. (D)The observed gold particle cluster size
distribution was simulated as in (C) with the assumption of an underlying
laminar BCR oligomer geometry. (E) Our simulations predict that 60% of all
receptors are part of oligomers of size 18 in a laminar geometry and 40%
are BCR dimers. (F) Gold cluster counts (dots with error bars) compared to
the prediction of best fitting model (continuous line). The number of counts
originating from the different underlying BCR oligomer sizes are shown as
dashed lines, indicating that observed clusters up to a size of 3 are primarily
caused by BCR dimers, while gold clusters larger than 3 can be explained by
BCR clusters of size 18. The impact of BCR monomers is negligible.
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FIGURE 5 |The IgD-hSbap BCR mutant forms mainly BCR dimers on the
surface of B cells. (A) IgD-hSbap BCR mutant-expressing J558L cells were
immuno-gold stained and analyzed as in Figure 4A. (B) 83% of the gold
particles were monomeric, 13% formed dimers, and 4% were present in
clusters of sizes larger than 2. (C) The observed gold particle cluster size
distribution was simulated for different BCR staining efficiencies (x -axis) and
different underlying BCR oligomer sizes (color scale). The sigma/p-values for
the statistical analysis of each simulation set are given on the y -axis. BCR
dimers with a staining efficiency of 8% are identified as the most likely
explanation for the observed gold cluster distribution. (D) Simulations were
performed as in (C). Assuming a staining efficiency of approximately 8%
(color coding), sigma/p-values (y -axis) are plotted for the different BCR
oligomer sizes (x -axis). (E) Gold cluster counts (dots with error bars)
compared to prediction of best fitting model (continuous line). The number of
counts originating from monomers and dimers are shown as dashed lines,
indicating that the observed distribution is dominated by BCR dimers. (F) A
model with BCR monomers and dimers was fitted to the data, predicting that
90% of all receptors are part of dimers, 10% are monomers.
staining efficiency of 8.8% (Figure 5C). The efficiency value is
not too far from the wt IgD-BCR staining efficiency, which has
been measured to be 15%. Our Monte-Carlo simulation indi-
cated that IgD-hSbap BCR oligomers larger than two can be
rejected at high confidence level unless the staining efficiency
would be lower than 5% (Figure 5D). Also BCR monomers
without larger BCR oligomers cannot explain the data, thus,
confirming that the mutant BCR dimerizes. In addition to the
single size model, a model with monomers and one further BCR
oligomer size was tested. The observed gold cluster distribution
after immuno-gold-labeling of the mutant IgD-BCR together with
the model prediction of the best fitting model, i.e., monomers
plus dimers, is shown in Figure 5E. Analogously to the wt IgD-
BCR experiment, the percentage of IgD-hSbap BCR present as
BCR monomers and BCR dimers was computed, demonstrating
that 90% of the mutant BCRs are present as dimers and 10%
as monomers (Figure 5F). These findings validate our approach
and reflect the Blue Native gel electrophoresis data for IgD-hSbap
BCR (16).
4. CONCLUSION
Here, we used a combined immuno-gold TEM and modeling
approach to suggest that the IgD-BCR is expressed as BCR
dimers and larger oligomers. To measure the distribution of cell
surface molecules super resolution light microscopy techniques,
such as high-speed photoactivated localization microscopy (5) or
dSTORM (21), have been employed. Unlike these light microscopy
techniques, our technique permits nano-scale resolution of cell
surface molecules on the membranes that are not in contact with
any support, thereby avoiding visualization of potential clustering
artifacts induced by cell adherence (26). This advantage is not given
in other EM methods, such as nano-probe labeling and transmis-
sion microscopy of cytoplasmic face-up sheets of cell membrane
ripped off from cells to generate cytoplasmic face-up membrane
sheets (27), which subsequently can be fixed and immuno-gold
labeled (5,28,29). Our method can measure the distribution of any
cell surface molecule, without the need to genetically modify this
protein with a fluorophore, provided that antibodies against the
protein are available. It is, however, not compatible with dynamic
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observations and, given the relatively low labeling efficiency, does
not allow absolute quantifications by direct gold counting; here we
present an approach to overcome the latter limitation. We assumed
that the presence of one gold particle is indicative of one BCR (with
the restraint that some gold particles are aggregated, which we
have taken into account). There is the unlikely possibility that our
staining approach with a primary anti-BCR and a secondary gold-
coupled antibody could allow for double labelings of the BCRs, if
the secondary antibody binds twice to the primary antibody (once
to each of the two heavy chains). However, double labeling most
likely did not take place: we used the IgD-hSbap BCR that only
formed monomers and dimers when analyzed by Blue Native gels
(16). And indeed, in our analysis this mutant BCR was exclusively
detected as monomers (10% of the BCRs) and dimers (90% of the
BCRs). These relative abundancies fit well to the biochemical Blue
Native gel data (16). Thus, we conclude that a potential double
gold-labeling of a BCR does not take place in our experiments and
does not prevent drawing our conclusions from the immuno-gold
TEM data. Here, we estimate that 60% of all wild type IgD-BCRs
expressed on J558Lδm/mb-1flN cells are part of BCR oligomers
of a size of around 18 and 40% form BCR dimers. This notion is
based on the most simple BCR size distribution (i.e., assuming the
lowest number of different BCR sizes) to explain the observed gold
distribution. Still, the co-existence of larger number of different
BCR oligomer sizes cannot be ruled out. Previously, the oligomer
size of the IgM-BCR has been theoretically approached by Iber
and Gruhn (30). Assuming oligomer formation and decay rates
based on the literature, they calculated that IgM-BCR pentamers
might exist. However, the modeling approach was not based on
experimental data on BCR oligomer sizes and thus the presence of
BCR pentamers is rather hypothetical. BCR pre-clustering might
increase the antigen-receptor avidity, since functional antigens are
mostly multimeric structures (31, 32). This increase in avidity
could enhance the sensitivity of B cell activation, as suggested
for TCR pre-clusters (8–10). BCR oligomers could also enhance
the sensitivity of B cells by cooperativity between BCRs in one
oligomer. Thus, antigen-binding to one or two BCRs could also
lead to the activation of non-engaged BCRs, propagating the signal
within one oligomer. In line with this, we had suggested earlier that
the kinase Syk bound to one BCR can phosphorylate the neigh-
boring BCR amplifying BCR signaling by a positive feedback loop
(33). In T cells it was shown experimentally that individual TCRs
cooperate in this manner within one TCR pre-cluster (34). On the
other hand, enhanced sensitivity of the B cells might also bear an
increased risk of reacting against abundant self-antigens and lead
to autoimmunity. The presence of pre-formed BCR oligomers has
important implications for the mechanism of how the BCR trans-
mits the signal of antigen-binding into the interior of the cells.
Initially, it was assumed that the BCRs are individually distributed
on the B cell surface and only brought into close proximity by their
multivalent antigens, leading to reciprocal phosphorylation of the
cytoplasmic tyrosines in Igα and Igβ and thereby signal initiation.
The idea of cross-linking as the first step in BCR activation was
based on the finding that monovalent antigens do not induce BCR
activation (31, 32). Now, the cross-linking model is questioned by
the finding that BCR oligomers exist (16, 17, 19, 21, 35). In our
analysis we hardly detected any BCR monomers, which is in line
with the finding that only oligomerized are stably expressed on the
cell surface (19). Our study clearly points out that BCR oligomers
of different sizes co-exist on the surface of resting B cells. Activa-
tion therefore might occur according to conformational changes
within the BCR oligomer, as e.g., the proposed in the dissociation
activation model (20). Knowledge on the pre-clustering of a given
receptor not only aids to explain the biology of the receptor, but
also might open new strategies for interfering with its function for
vaccination or therapeutic purposes.
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